Elsevier

Neuroscience

Volume 77, Issue 1, 6 January 1997, Pages 257-270
Neuroscience

Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem

https://doi.org/10.1016/S0306-4522(96)00434-4Get rights and content

Abstract

Central administration of the preproglucagon-derived peptide glucagon-like peptide-1 significantly inhibits ingestion of food and water, and glucagon-like peptide-1 binding sites are present in a multitude of central areas involved in the regulation of ingestional behaviour. To evaluate further the neuroanatomical organization of central glucagon-like peptide-1 containing neuronal circuits with potential implications on ingestional behaviour, we carried out a series of experiments in the rat demonstrating the topographical sites of synthesis and processing of the preproglucagon precursor followed by a chromatographic analysis of the processed fragments. In situ hybridization histochemistry revealed that preproglucagon encoding messenger RNA was expressed in a single population of neurons in the caudal portion of the nucleus of the solitary tract. Gel chromatographic analysis of hypothalamic and brainstem tissue extracts revealed that the preproglucagon precursor is processed in a fashion similar to that seen in the small intestine, preferentially giving rise to glicentin, glucagon-like peptide-1 and glucagon-like peptide-2. This single brain site of glucagon-like peptide-1 synthesis was subsequently confirmed by immunohistochemical demonstration of glucagon-like peptide-1-immunoreactive perikarya in the central and caudal parts of the nucleus of the solitary tract. Numerous sites containing glucagon-like peptide-1 immunoreactive fibres were, however, discovered in the forebrain including hypothalamic, thalamic and cortical areas. The densest innervation by glucagon-like peptide-1 immunoreactive nerve fibres was seen in the hypothalamic dorsomedial and paraventricular nuclei, but numerous glucagon-like peptide-1 immunoreactive fibres were also seen throughout the periventricular strata of the third ventricle. Dual-labelling immunohistochemistry for tyrosine hydroxylase and glucagon-like peptide-1 gave no evidence for co-localization of catecholamines and glucagon-like peptide-1 in neurons of the lower brainstem. To identify neurons of the nucleus of the solitary tract that project to the hypothalamic paraventricular nucleus, the retrograde tracer FluoroGold was injected into this hypothalamic target and dual immunocytochemical identification of glucagon-like peptide-1 and tyrosine hydroxylase-positive neurons was performed on brainstem sections containing retrogradely labelled perikarya. From this experiment it was seen that many of the retrogradely labelled neurons in the central portion of the nucleus of the solitary tract are catecholaminergic, while none is glucagon-like peptide-1 immunoreactive. In contrast, most of the retrogradely labelled neurons of the caudal portion of the nucleus of the solitary tract contain glucagon-like peptide-1.

These observations further substantiate that glucagon-like peptide-1 neurons of the solitary tract constitute a distinct non-catecholaminergic cell group which projects to many targets, one of which is the hypothalamic paraventricular nucleus.

Section snippets

Animals

Fifty-five adult male Wistar rats (200–250 g; Panum Institute Colony) were used in this study. The rats had unlimited access to pellet chow and water, and they were housed under standard laboratory conditions with lights on from 6.00 a.m. to 6.00 p.m.

Chromatography

Thirty rats were decapitated between 9.00 and 10.00 a.m., and their brains were removed and rapidly frozen on dry ice. Tissue blocks containing the rostral portion of the hypothalamus and brainstem blocks were dissected and pooled. The two tissue

Gel chromatography

Upon gel filtration of the extracts of rat hypothalamus and brainstem, similar elution patterns of all measured moieties were found in the two areas (Fig. 2). The peptide concentrations/g tissue (wet weight), however, were significantly higher in the hypothalamus than in the brainstem (7 pmol/g vs 0.1 pmol/g). In both areas almost all GLP-1 immunoreactivity (as measured with antisera nos 2135 and 89390) eluted at the position of synthetic GLP-1 (7–36 amide) (Kd 0.60). The brain peptide must be

Discussion

The present study confirms the presence of a single population of GLP-1-synthesizing neurons in the caudal brainstem and provides evidence that this population of cells contributes to the terminal field of at least one hypothalamic target. Furthermore, the dual-labelling experiments indicate that this population of GLP-1 cells is distinct from the catecholaminergic cells of the NTS, supporting the view that the parvicellular neurons of the PVN receive neurochemically diversified inputs from

Conclusions

The present data clearly demonstrate that a population of non-catecholaminergic solitary tract neurons produces fully processed GLP-1 from the preproglucagon precursor. Furthermore, it is clear that this group of neurons projects to the PVN. Given the apparent absence of other GLP-1-IR neurons in the CNS, these neurons are the only source of central GLP-1-containing nerve fibres.

References (39)

  • R Eissele et al.

    Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man

    Eur. J. clin. Invest.

    (1992)
  • R Göke et al.

    Identification of specific binding sites for GLP-1(7–36)amide on the posterior lobe of the rat pituitary

    Neuroendocrinology

    (1995)
  • R Göke et al.

    Distribution of GLP-1 binding sites in the rat brain. Evidence that exendin-4 is a ligand of brain GLP-1 binding sites

    Eur. J. Neurosci.

    (1995)
  • V.K.M Han et al.

    Cellular localization of proglucagon/glucagon-like peptide 1 messenger RNAs in rat brain

    J. Neurosci. Res.

    (1986)
  • G Heinrich et al.

    Pre-proglucagon messenger ribonucleic acid: nucleotide encoded amino acid sequences of complementary deoxyribonucleic acid

    Endocrinology

    (1984)
  • J.J Holst

    Evidence that glicentin contains the entire sequence of glucagon

    Biochem. J.

    (1980)
  • J.J Holst

    Evidence that enteroglucagon (II) is identical with the C-terminal sequence (residues 33–69) of glicentin

    Biochem. J.

    (1982)
  • J.J Holst et al.

    Assays for peptide products of somatostatin expression

    Meth. Neurosci.

    (1991)
  • S.M Hsu et al.

    Use of avidin–biotin–peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabelled antibody (PAP) procedures

    J. Histochem. Cytochem.

    (1981)
  • Cited by (532)

    View all citing articles on Scopus
    View full text